| Title: |
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis |
| Authors: |
Reginster, Jean-YvesAff1; Czerwinski, EdwardAff2; Wilk, KrzysztofAff2; Borowy, PrzemysławAff2; Strzelecka, AnnaAff3; Budlewski, TomaszAff3; Janowska-Maus, MonikaAff3; Szymanowski, KrzysztofAff4; Kwiatek, JoannaAff5; Postol, SvitlanaAff6; Põder, AiriAff7; Supronik, JerzyAff8; Kim, SungHyunAff9; Suh, JeeHyeAff9; Han, NooRiAff9; Kim, NaHyunAff9; Bae, SeoHeeAff9; Silverman, Stuart L.Aff10, IDs0019802407161x_cor18 |
| Source: |
Osteoporosis International: With other metabolic bone diseases. 35(11):1919-1930 |
| Database: |
Springer Nature Journals |